New York State Common Retirement Fund’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $79K | Hold |
32,734
| – | – | ﹤0.01% | 2808 |
|
|
2025
Q1 | $72K | Hold |
32,734
| – | – | ﹤0.01% | 2654 |
|
|
2024
Q4 | $178K | Hold |
32,734
| – | – | ﹤0.01% | 2352 |
|
|
2024
Q3 | $272K | Sell |
32,734
-136,537
| -81% | -$1.13M | ﹤0.01% | 2171 |
|
|
2024
Q2 | $1.21M | Buy |
169,271
+10,771
| +7% | +$77.1K | ﹤0.01% | 1673 |
|
|
2024
Q1 | $1.37M | Sell |
158,500
-55,288
| -26% | -$479K | ﹤0.01% | 1629 |
|
|
2023
Q4 | $1.4M | Buy |
213,788
+4,079
| +2% | +$26.7K | ﹤0.01% | 1620 |
|
|
2023
Q3 | $2.1M | Buy |
209,709
+107,224
| +105% | +$1.07M | ﹤0.01% | 1435 |
|
|
2023
Q2 | $1.27M | Sell |
102,485
-23,578
| -19% | -$293K | ﹤0.01% | 1670 |
|
|
2023
Q1 | $1.77M | Sell |
126,063
-35,696
| -22% | -$500K | ﹤0.01% | 1601 |
|
|
2022
Q4 | $2.32M | Buy |
161,759
+24,255
| +18% | +$347K | ﹤0.01% | 1564 |
|
|
2022
Q3 | $3.51M | Buy |
137,504
+21,617
| +19% | +$552K | 0.01% | 1328 |
|
|
2022
Q2 | $3.29M | Sell |
115,887
-2,833
| -2% | -$80.5K | ﹤0.01% | 1395 |
|
|
2022
Q1 | $4.19M | Sell |
118,720
-4,896
| -4% | -$173K | ﹤0.01% | 1364 |
|
|
2021
Q4 | $5.18M | Buy |
123,616
+7,483
| +6% | +$314K | 0.01% | 1285 |
|
|
2021
Q3 | $5.7M | Buy |
116,133
+32,333
| +39% | +$1.59M | 0.01% | 1259 |
|
|
2021
Q2 | $3.5M | Buy |
83,800
+39,000
| +87% | +$1.63M | ﹤0.01% | 1516 |
|
|
2021
Q1 | $1.6M | Buy |
+44,800
| New | +$1.6M | ﹤0.01% | 1908 |
|